Article
Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1b.
The protein journal - 1 Feb 2012
Glisic Sanja, Veljkovic Nevena, Jovanovic Cupic Snezana, Vasiljevic Nada, Prljic Jelena, Gemovic Branislava, Perovic Vladimir, Veljkovic Veljko
Abstract excerpt
Hepatitis C virus (HCV) infection is a major and rising global health problem, affecting about 170 million people worldwide. The current standard of care treatment with interferon alpha and ribavirin in patients with the genotype 1 infection, the most frequent genotype in the USA and Western Europe, leads to a successful outcome in only about 50% of individuals. Accurate prediction of hepatitis C treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
